/

Sociétés

As

Non vérifié

AskBio Inc. (AskBio)

Ce que nous écrivons

BiotechnologiePublicité/Marketing/Médias/Communication

3 communiqués de presse

Voir tous les communiqués de presse

11/05/2026

Biotechnologie

Publicité/Marketing/Médias/Communication

First Participant Dosed in AskBio Phase 1/Phase 2 Gene Therapy Trial of AB-1009 for Late-Onset Pompe Disease (LOPD)

Source

AskBio Inc. (AskBio)

Émetteur

1.00

0

31/03/2026

Biotechnologie

Publicité/Marketing/Médias/Communication

AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure

Source

AskBio Inc. (AskBio)

Émetteur

1.00

0

22/09/2025

Biotechnologie

Publicité/Marketing/Médias/Communication

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

Source

AskBio Inc. (AskBio)

Émetteur

1.00

0

Followers

0

Compatibilité

0